Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with Stelo. Stelo, the company’s FDA-cleared over-the-counter (OTC) glucose biosensor, now gives users 24/7 glucose insights via the Oura app. Oura’s new in-app metabolic health feature, Glucose, now gives Oura members a deeper understanding of how dietary choices impact health. […]
Oura
Dexcom CEO says 2025 is ‘shaping up to be a good year’ with Stelo launch, GenAI integration
After a busy 2024, Dexcom (Nasdaq:DXCM) Chair and CEO Kevin Sayer believes the company is set for more milestones in 2025. In 2024, the company became the first to receive FDA approval for an over-the-counter (OTC) continuous glucose monitor (CGM), the Stelo device. Meanwhile, Dexcom continues to advance its G7 platform, its latest-generation CGM offering. […]
Oura raises $200M from investors including Dexcom
Oura announced today that it completed a $200 million Series D funding round that included Dexcom (Nasdaq:DXCM). The investment comes as part of a new health monitoring partnership between the continuous glucose monitor (CGM) maker and Oura, the maker of smart ring technology. Fidelity Management & Research Co. also contributed to the financing. San Francisco–based Oura says the financing round […]
Dexcom invests $75M in Oura as companies strike health monitoring partnership
Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring technology. The partnership aims to help people improve their metabolic health by integrating Dexcom glucose data with vital sign, sleep, stress, heart health and activity data from the Oura Ring. Combining glucose data with biometrics can deliver […]
